• Home

Home > Medical Reference > Encyclopedia (English)

Toggle: English / Spanish

Secondary parkinsonism

• Overview
• Symptoms
• Treatment
• Prevention

Definition:

Secondary parkinsonism is similar to Parkinson's disease , but is caused by certain medicines, an different nervous system disorder, or another illness.

Alternative Names:

Parkinsonism - secondary

Causes, incidence, and risk factors:

Parkinson's disease is one of the most common neurologic disorders of the elderly. The term "parkinsonism" refers to any condition that causes any combination of the types of movement abnormalities seen in Parkinson's disease by damaging or destroying dopamine neurons in a certain area of the brain.

Secondary parkinsonism may be caused by disorders such as a stroke , encephalitis , or meningitis . Other neurodegenerative disorders such as progressive supranuclear palsy, corticobasal degeneration, and multiple systems atrophy can also damage the dopamine neurons and produce this condition.

Medications including antipsychotics such as haloperidol, metoclopramide, and phenothiazine medications are another common cause of secondary parkinsonism.

Less frequently, exposure to overdoses of narcotics or brain damage caused by anesthesia agents (such as during surgery); exposure to toxins , and carbon monoxide poisoning can cause secondary parkinsonism if they damage the brain area that contains the dopamine neurons.

There have been clusters of cases among intravenous drug users who injected a substance called MPTP, which is a byproduct of an improper technique for synthesizing a form of synthetic heroin (fentanyl derivative). These cases are rare and have affected primarily long-term drug users.

Secondary parkinsonism caused by medications like antipsychotics is usually reversible. If it is caused by toxins, infections, drug-related brain damage, or certain other disorders it may or may not be reversible.

Symptoms of parkinsonism may include stiffness of the trunk, arms, or legs, a decrease in facial expression, soft voice, tremor, some forms of paralysis, and certain problems with control of movement.

Although cognitive dysfunction is not a major feature of Parkinson's disease, it may be more prominent in secondary parkinsonism as the diseases that cause secondary parkinsonism more commonly also result in dementia.

References:

U.S. Food and Drug Administration. FDA Approves Neupro Patch for Treatment of Early Parkinson's Disease . Rockville, MD: National Press Office; May 9, 2007. Release P07-84.

Goetz, CG. Textbook of Clinical Neurology . 2nd ed. St. Louis, Mo: WB Saunders; 2003: 713-720.

Noble J. Textbook of Primary Care Medicine . 3rd ed. St. Louis, Mo: Mosby; 2001:1612-1618.

• Review Date: 5/9/2007
• Reviewed By: Updated by: A.D.A.M. Editorial Team: Greg Juhn, M.T.P.W., David R. Eltz, Kelli A. Stacy. Previously reviewed by Gail A. Kang, M.D., San Francisco VA Parkinson's Disease Research, Education, & Clinical Center, San Francisco, CA. Review provided by VeriMed Healthcare Network.(8/26/2006)

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process . A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 1997-2007 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.